EU - OHE - Page 66

Office of Health Economics

Leading intellectual authority on global health economics

Search publications, topics, authors and more

Newsletter SignupSubscribe

News & Insights

News
Events
Insights
Bulletin

News
Events
Insights
Bulletin

News & Insights

News
Events
Insights
Bulletin

Newsletter SignupSubscribe

News
Events
Insights
Bulletin

Search publications, topics, authors and more

Research & Publications
News & Insights
Education
Innovation Policy Prize

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:

Antimicrobial Resistance (AMR)
Biosimilars
Cell and Gene Therapies
Chronic Diseases
Combination Therapies
COVID-19 Research
Digital Health
Drug Development/R&D
Emerging Markets
EQ-5D and PROMs
Health Care Systems
Health Data and Statistics
Health Technology Assessment
Precision Medicine
Prevention
Real-World Evidence
Sustainability
Use of Medicines
Value-Based Pricing
Vaccine Research

Economics of Innovation
Measuring and Valuing Outcomes
Policy, Organisation and Incentives in Health Systems
Value, Affordability and Decision Making

News & Insights

News
Events
Insights
Bulletin

Education

Education Hub
OHE Graduate School
EVIA Programme

Innovation Policy Prize

The Prize Fund
2024 Prize Fund
2022 Prize Fund

Search publications, topics, authors and more

Latest Research & Publications

Health Care Systems
Policy, Organisation and…
Healthcare Delivery

NHS Reorganisation

Parkinson’s Disease

Benefits and Risks and Medical Care: a Symposium Held by the Office of Health Economics

Health Policy and Regulation

Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group

The Ideas and Influence of Alan Williams: Be Reasonable – Do It My Way

Policy, Organisation and…

Dental Service

All Publications

Filter by:

Antimicrobial Resistance (AMR)

Biosimilars

Cell and Gene Therapies

Chronic Diseases

Combination Therapies

COVID-19 Research

Digital Health

Drug Development/R&D

Emerging Markets

EQ-5D and PROMs

Health Care Systems

Health Data and Statistics

Health Technology Assessment

Precision Medicine

Prevention

Real-World Evidence

Sustainability

Use of Medicines

Value-Based Pricing

Vaccine Research

Economics of Innovation

Measuring and Valuing Outcomes

Policy, Organisation and Incentives in Health Systems

Value, Affordability and Decision Making
News

Events

Insights

Bulletin
Education Hub

OHE Graduate School

EVIA Programme
The Prize Fund

2024 Prize Fund

2022 Prize Fund

Events
About Us
OHE Experts
Join OHE
Contact Us

Newsletter SignupSubscribe

Filter results by

Theme

Select the product option you would like to filter Theme

Economics of Innovation Measuring and Valuing Outcomes Policy, Organisation and Incentives in Health Systems Value, Affordability, and Decision Making

Topic

Select the product option you would like to filter Topic

Antimicrobial Resistance (AMR) Biosimilars Cell and Gene Therapies Chronic Diseases Combination Therapies COVID-19 Research Dementia Digital Health Drug Development/R&D Emerging Markets EQ-5D and PROMs Health Care Systems Health Data and Statistics Health Technology Assessment (HTA) Innovation Policy Prize OHE Consulting Precision Medicine Prevention Real World Evidence (RWE) Research Sustainability Use of Medicines Vaccines Value-Based Pricing

Tag

Select the product option you would like to filter Tag

Adult Immunisation Alzheimer's Cancer Cardiovascular Disorders Care-givers Caring burden Cervical Cancer Clinical Outcomes Commentary Competition Dermatology Determining Value Drug Shortages Economic Evaluation Egypt Epidemiology and Public Health Epilepsy Gene therapies Generics Greece Haemophilia Health Policy and Regulation Healthcare Delivery Healthcare Expenditure Healthcare Funding Healthcare System Pressure (HCSP) India Infectious Diseases Inflation Reduction Act Injury and Trauma Innovation Israel Market Access Mental Health Pharmaceutical Industry Plant-based Policy Analysis Pricing and Reimbursement Primary Care Quality of Care Quality of Life Rare and Orphan Diseases Research Funding Resource Allocation Saudi Arabia Slovak Republic Supply of Medicine Türkiye Unmet Need Vaccines Value based pricing Webinar

Date 1

Select the product option you would like to filter Date

Date From

Month From

Year From

Date To

Month To

Year To

Author

Select the product option you would like to filter Author

Search authors

Lishani Ramanayake Sukanya Subramaniyan Brittany Darrow Henry Fong Yi Wang Chittawan Poonsiri Manit Sittimart Sarin Kc Hannah Hussain Dr. Sabine Vogler

Content Type

Select the product option you would like to filter Content Type

news story insight events podcast bulletin publications

News
February 2011

Comparing Variants of Lead and Lag Time TTO

News
January 2011

The Market for Biosimilars

News
January 2011

Economic Evidence and NHS Reforms in England

Value, Affordability, and…

Critical Review of the Quality and Competition Measures and Identification Strategies Used in Health Care Studies

Measuring and Valuing Outcomes
Clinical Outcomes

Valuing Health at the End of Life: An Exploratory Preference Elicitation Study

News
January 2011

Update: Value-Based Pricing in the UK

Economics of Innovation
Market Access

Health and the Use of Medicines in Primary Care in Wales

Value, Affordability, and…
Clinical Outcomes

Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?

Antimicrobial Resistance (AMR)
Economics of Innovation
Generics

Summary Report of the OHE/EFPIA Antibacterial Roundtable

Health Care Systems
Policy, Organisation and…
Quality of Care

The Effect of an Increase in the Rate of Payment on General Practitioner’s Intrinsic and Extrinsic Motivation

Measuring and Valuing Outcomes
Clinical Outcomes

Using Happiness to Value Health

Value-Based Pricing
Economics of Innovation
Health Policy and Regulation

Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches

Health Data and Statistics

OHE Guide to UK Health and Health Care Statistics

Health Care Systems
Policy, Organisation and…
Cancer

Achieving World Class Outcomes in Cancer Treatment

Health Technology Assessment…
Value, Affordability, and…

Is the Aim of the Health Care System to Maximise QALYs? An Investigation of

News
January 2011

Measuring Value: OHE at ISPOR

Leading intellectual authority on global health economics

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Cookies Policy

An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Twitter

Facebook

Copy

Share on Mastodon

Enter your Mastodon instance URL (optional)

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies

Please enable Strictly Necessary Cookies first so that we can save your preferences!

News & Insights

Latest Research & Publications

NHS Reorganisation

Parkinson’s Disease

Benefits and Risks and Medical Care: a Symposium Held by the Office of Health Economics

Estimating Pharmaceutical Companies’ Value to the Nation: Case Study of the British Pharma Group

The Ideas and Influence of Alan Williams: Be Reasonable – Do It My Way

Dental Service

Age of Maturity

Obesity and disease

All Publications

Filter results by

Comparing Variants of Lead and Lag Time TTO

The Market for Biosimilars

Economic Evidence and NHS Reforms in England

Critical Review of the Quality and Competition Measures and Identification Strategies Used in Health Care Studies

Valuing Health at the End of Life: An Exploratory Preference Elicitation Study

Update: Value-Based Pricing in the UK

Health and the Use of Medicines in Primary Care in Wales

Willingness to Pay and Publicly Funded Health Care: Contradiction in Terms?

Summary Report of the OHE/EFPIA Antibacterial Roundtable

The Effect of an Increase in the Rate of Payment on General Practitioner’s Intrinsic and Extrinsic Motivation

Using Happiness to Value Health

Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches

OHE Guide to UK Health and Health Care Statistics

Achieving World Class Outcomes in Cancer Treatment

Is the Aim of the Health Care System to Maximise QALYs? An Investigation of

Measuring Value: OHE at ISPOR

Share on Mastodon